Boundless Bio Inc. is a clinical-stage oncology company focused on developing precision cancer therapies for tumors driven by oncogene amplification. Its work centers on extrachromosomal DNA (ecDNA), a biological mechanism that can fuel cancer growth, adaptation, and resistance to existing treatments. Using its proprietary Spyglass platform, Boundless Bio identifies ecDNA-related targets and designs ecDNA-directed therapeutic candidates intended to disrupt the pathways cancer cells use to survive. The company’s current pipeline includes oral small-molecule programs such as BBI-940 and other ecDNA-directed therapies being evaluated in clinical studies across hard-to-treat cancer types. Boundless Bio Inc. operates in the biotechnology sector and serves the broader oncology market with a research-driven approach aimed at addressing unmet needs in patients with oncogene-amplified cancers.
Website10955 Alexandria Way
San Diego, CA, 92121
United States
Investors talking about BOLD also mention
| # | Name | Attention |
|---|---|---|
| 1 | Regenxbio Inc.RGNX | 0%+0 |
| 2 | Beam Therapeutics IncBEAM | 0.02%+0.02 |
| 3 | MeiraGTx Holdings plcMGTX | 0%new |
| 4 | Prime Medicine, Inc.PRME | 0%-0.01 |
| 5 | ProQR Therapeutics N.V. Ordinary SharesPRQR | 0%0 |
| 6 | Passage Bio Inc.PASG | 0%0 |
| 7 | Qiagen N.V.QGEN | 0%+0 |
| 8 | ACHL - Achilles Therapeutics plc | —— |
| 9 | Metagenomi Therapeutics, Inc.MGX | 0%0 |
| 10 | BioMarin Pharmaceutical IncBMRN | 0%+0 |
What share of all stock conversation is about BOLD?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% new | 0% new | 0% new | 0% 0 |
Of the messages about BOLD that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | — | 99.78% +39.83 | ||
| Bearish | — | — | — | 0.22% -39.83 |
Of the messages about BOLD that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | 50% | 50% | 50% | 43.6% | ||
| Controversies | 50% | 50% | 50% | 25.16% | ||
| Analysts | 0% | 0% | 0% | 0% | ||
| Earnings | 0% | 0% | 0% | 0% | ||
| Macro | 0% | 0% | 0% | 10.74% | ||
| Technical Analysis | 0% | 0% | 0% | 20.5% |
Of the messages about BOLD, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 0% | 0% | 0% | 3.63% | ||
| Newcomers | 100% | 100% | 100% | 96.37% |